Aisling Capital Raising Third Fund

Aisling Capital, a New York-based growth capital firm focused on the life sciences sector, is raising up to $750 million for its third fund, according to a Sept. 2 regulatory filing. It already has secured around $580 million worth of commitments. Aisling – formerly known as Perseus-Soros Management – closed its second fund on $550 million in 2005.